All figures below come from the Griffin report below or todays...

All figures below come from the Griffin report below or todays placement announcement.

http://www.unilife.com/index.php?option=com_content&task=category§ionid=1&id=1&Itemid=76

Ive done the numbers on the facts and this is what my little brain comes up with.

Capex from the griffin report for all years out to 2013 totalled $ 56M (Revenue $257M) include 2014 and its $94M (Revenue $388M).

The current capital raising brings $42.1M now and in three years time a further $30M for a total of $72.7M.

As stated the funds will be used to
*Improve the bargaining position
*Allow funding for other product lines such as clinical range.
*Bring fwd prefill production
*Assist with NASDAQ listing requirements

So in the period up to 2014 net cash flow as per Griffin was $194M plus the $72M of funds raised today for a total of $266M................ Capex for the period was $94M leaving free cash of $172M.

So as stated they spend the raised funds to increase production and we use the capex figures given they could possibly bring fwd the production by say two further years giving us revenue of $388M in 2012. Then calculate how they spend the other $172m developing the clinical range and 1m lines plus whatever else they have in the bag.

The cost of this is about a 30% dilution of the stock vs the revenue brought fwd by years and a faster pipeline to the next growth area.

End result for me is rather than waiting 6 or 7 years to achieve sales of $1B we could see it 4 to 5. Not a bad deal from my point of view.

Add in sales from other pharmas and new products and we see numbers I dont even want to contemplate!!! Ohh well yes I do.......

My vote will be to hold onto my shares and do nothing... just watch the grass grow and the revenue rise and rise!!!

Once again well done to the big fella he has derisked the launch even further since the Sanofi deal and has $172M worth of cash giving him options above the Griffin report numbers we dont even know about yet. I agree with writer............BRILLIANT......................